2006
DOI: 10.1515/cclm.2006.267
|View full text |Cite
|
Sign up to set email alerts
|

10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2007
2007
2012
2012

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 2 publications
0
10
0
Order By: Relevance
“…Therefore, due to the specific release pattern of troponin following myocardial injury (HD lasted less than 4 hr and troponin concentrations in blood increase only from 4 to 6 hr after onset of chest pain) (43), the changes observed could be most conceivably attributed to HD. At variance with previous investigations that used the lower limit of the analytical sensibility of the assay, we applied a more reliable diagnostic threshold, corresponding to the lowest cTnT concentration associated with a 10% total imprecision (33). Finally, we could rule out any bias from hemoconcentration, since results of each biomarker were adjusted for the plasma volume changes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, due to the specific release pattern of troponin following myocardial injury (HD lasted less than 4 hr and troponin concentrations in blood increase only from 4 to 6 hr after onset of chest pain) (43), the changes observed could be most conceivably attributed to HD. At variance with previous investigations that used the lower limit of the analytical sensibility of the assay, we applied a more reliable diagnostic threshold, corresponding to the lowest cTnT concentration associated with a 10% total imprecision (33). Finally, we could rule out any bias from hemoconcentration, since results of each biomarker were adjusted for the plasma volume changes.…”
Section: Discussionmentioning
confidence: 99%
“…Serum albumin and creatinine were measured on the Modular System P, using proprietary reagents (Roche Diagnostics GmbH), whereas cTnT, CK-MB, and myoglobin were assayed on an Elecsys 2010 platform (Roche Diagnostics GmbH). Although the detection limit for cTnT is 0.01 ng/mL, the recommended diagnostic threshold for myocardial injury is 40.03 ng/mL, which corresponds to the lowest TnT concentration associated with a 10% total imprecision in the assay (33). Threshold retained for CK-MB was 6 mg/L.…”
Section: Laboratory Methodsmentioning
confidence: 99%
“…cTnT was assessed on a Modular System E (Roche Diagnostics GmbH, Mannheim, Germany). cTnT results were stratified according to the diagnostic threshold (i.e., [0.03 ng/ml), which corresponds to the lowest cTnT concentration associated with a 10% total imprecision in the laboratory assay [24]. All patients underwent a standard 12-lead electrocardiogram, which was interpreted by an experienced cardiologist according to conventional criteria.…”
Section: Methodsmentioning
confidence: 99%
“…cTnT was assayed on the Elecsys 2010 (Roche Diagnostics GmbH, Mannheim, Germany). Test results were stratified according to the decisional threshold corresponding to the lowest TnT concentration associated with a 10% total imprecision in the assay (>0.03 lg/l) [7]. The samples were centrifuged at 1,500g for 20 min at room temperature and immediately analyzed.…”
Section: Methodsmentioning
confidence: 99%